In a bipartisan spending agreement that was largely negotiated behind closed doors, Congress included a policy change with ...

The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have ...

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.

If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...

Dartmouth hospital CFO details 340B designation risk and strategic partnership to safeguard federal program participation at ...

Illinois is facing an intense battle over a federal program requiring drug manufacturers to sell deeply discounted ...

Washingtonians are struggling to afford already high health care costs, and those costs keep climbing. Sadly, I’ve seen this firsthand in my rheumatology practice, where patients are faced with ...

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

(The Center Square) – Hospitals and clinics in Michigan participating in a federal drug discount program are marking up medications and shifting costs onto public employee health plans, according to a ...